首页> 外文期刊>Annals of thoracic and cardiovascular surgery: official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia >A case report of central extracorporeal membrane oxygenation after implantation of a left ventricular assist system: femoral vein and left atrium cannulation for ECMO.
【24h】

A case report of central extracorporeal membrane oxygenation after implantation of a left ventricular assist system: femoral vein and left atrium cannulation for ECMO.

机译:左心室辅助系统植入后中央体外膜氧合的一例报告:ECMO股静脉和左心房插管。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: The left ventricular assist system (LVAS) is often used for end-stage heart failure. However, in severe lung disorder, the patient needs extracorporeal membrane oxygenation (ECMO) because oxygenation using only a ventricular assist system (VAS) is insufficient. We report a successful case of combining the use of LVAS and right VAS (RVAS) with ECMO. METHOD: A 40-year-old female developed cardiogenic shock secondary to end-stage dilated cardiomyopathy, and percutaneous cardiopulmonary support (PCPS) was initiated. An echocardiogram showed a low ejection fraction (11%), and she underwent implantation of an LVAS (Toyobo Ventricular Assist System). She also required a RVAS with ECMO shunting between the right and left atrium because there was insufficient oxygenation resulting from pulmonary dysfunction followed by severe lung edema. RESULT: Pulmonary function recovered successfully, and the RVAS-ECMO was removed after 7 days of support. There were no complications after operation, such as infection, bleeding, or systemic embolization. CONCLUSION: LVAS combined with RVAS-ECMO in right and left atrial cannulation is a useful option for patients with severe pulmonary damage.
机译:目的:左心室辅助系统(LVAS)通常用于末期心力衰竭。然而,在严重的肺部疾病中,患者需要体外膜氧合(ECMO),因为仅使用心室辅助系统(VAS)进行氧合是不够的。我们报告了将LVAS和正确的VAS(RVAS)与ECMO结合使用的成功案例。方法:一名40岁女性因末期扩张型心肌病继发心源性休克,并开始经皮心肺支持(PCPS)。超声心动图显示低射血分数(11%),并且她接受了LVAS(Toyobo心室辅助系统)的植入。她还需要在右心房和左心房之间进行ECMO分流的RVAS,因为肺功能不全继而导致严重的肺水肿导致氧合不足。结果:肺功能成功恢复,并且在支持7天后去除了RVAS-ECMO。术后无并发症,如感染,出血或全身栓塞。结论:LVAS联合RVAS-ECMO在左右心房插管中是严重肺损伤患者的有用选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号